Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
345.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 30.00 (9.091%)
Market Cap: £32.96m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

PDMR and PCA Shareholding

3 Feb 2025 07:00

RNS Number : 5467V
Cropper(James) PLC
03 February 2025
 

James Cropper plc

(the "Company")

 

PDMR and PCA Shareholding

 

The Company has been notified that, on 31 January 2025, Mark Cropper (Non-Executive Chair) transferred 5,000 ordinary shares of 25p each ("Shares") in the Company to his son, James Cropper, for a consideration of £1.975 per Share.

 

In addition, following a change in age, the Company has been notified that 26,349 Shares in the Company previously reported within Mark Cropper's beneficial ownership have now transferred to the beneficial ownership of his son, James Cropper.

 

Following the above changes, the beneficial interests of Mark Cropper and his son, James Cropper, in the Company's share capital are as follows:

 

Shareholding

Mark Cropper

James Cropper

No. Shares

% share capital*

No. Shares

% share capital*

Beneficial

1,895,977

19.8

31,349

0.33

Non-beneficial

559,571

5.9

0

0

Total

2,455,548

26.0

31,349

0.33

*based on the Company's current issued Share capital of 9,554,803 Shares

 

Mark Cropper and members of the Cropper, Willink and Acland families are deemed to act in concert and are regarded by the Takeover Panel as being members of a concert party as detailed in the Company's circular to shareholders dated 30 June 2015 (the "Concert Party"). The Concert Party has a collective interest in 3,624,109 Ordinary Shares representing 37.9% of the Company's issued share capital.

Enquiries

 

James Cropper plc

Matt Ratcliffe, General Counsel and Company Secretary

Tel: +44 (0) 1539 722 002

 

Shore Capital - (NOMAD and Broker)

Daniel Bush, David Coaten, Henry Willcocks, Lucy Bowden

Tel: +44 (0) 7601 6100

 

Buchanan Communications - Financial PR

Chris Lane, Charles Ryland, Jamie Hooper, Verity Parker

jamescropper@buchanancomms.co.uk

Tel: +44 (0) 207 466 5000

 

 

 

 

The following information is included in accordance with Article 19(3) of the Market Abuse Regulation (No. 596/2014):

1.

Details of person discharging managerial responsibilities/person closely associated

 

a)

Name

(i) Mark Cropper

(ii) James Cropper

2.

 

Reason for the notification

a)

Position/status

(i) Mark Cropper: Non-Executive Chair

(ii) James Cropper: PCA of Mark Cropper

b)

Initial notification/amendment

Initial Notification

3.

Details of the issuer

 

a)

Name

James Cropper plc

 

b)

Legal Entity Identifier

213800XM78VTDYGBRM93

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

 

a)

Description of the

financial instrument

Ordinary Shares of 25 pence each

b)

Identification code of the Financial Instrument

GB0002346053

c)

Nature of the

transaction

(i) Sale of 5,000 Shares by Mark Cropper to James Cropper

(ii) Transfer of 26,349 Shares by Mark Cropper to James Cropper

d)

Currency

GBP

 

e)

Price(s) and volume(s)

 

Price(s)

Volume(s)

(i)

£1.975 per Share

5,000

(ii)

Nil

26,349

 

f)

Aggregated

information

- volume

- Price

- Total

 

 

 

(i) Volume: 5,000

(i) Price: £1.975

(i) Total: £9,875

 

(ii) Volume: 26,349

(ii) Price: Nil

(ii) Total: N/A

 

g)

Date of the transaction

31.01.2025

h)

Place of the transaction

Off market

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSDIFWFEISELF
Date   Source Headline
12th Jan 20247:00 amRNSDirectorate Update
21st Dec 20233:33 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSGrant of Awards under Long Term Incentive Plan
27th Nov 20237:00 amRNSBoard Appointment
24th Nov 20232:30 pmRNSDirectorate Change
9th Nov 20237:00 amRNSInterim Results
26th Oct 20237:00 amRNSNotice of Interim Results
26th Sep 20232:50 pmRNSResult of Annual General Meeting
26th Sep 20237:00 amRNSAGM Trading Update
4th Sep 20237:00 amRNSNotice of AGM
31st Aug 20237:00 amRNSInnovative production unit for green hydrogen
29th Aug 202312:43 pmRNSDividend Declaration
24th Aug 20237:00 amRNSFull Year Results
10th Aug 20237:00 amRNSNotice of Full Year Results
14th Jun 20237:00 amRNSDirectorship Change
7th Jun 20237:00 amRNSTFP HYDROGEN ANNOUNCES EXPANSION IN NORTH AMERICA
21st Apr 20235:18 pmRNSDirector/PDMR Shareholding
19th Apr 20237:00 amRNSTrading Update and Overview of Strategy
14th Feb 202312:00 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSDirector/PDMR Shareholding
31st Jan 20239:45 amRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSDirector/PDMR Shareholding
18th Nov 20229:48 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSHalf-year Report
31st Oct 20227:00 amRNSHalf Year Trading Update
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
12th Sep 202211:03 amRNSDirector/PDMR Shareholding
2nd Sep 20224:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20224:35 pmRNSPrice Monitoring Extension
26th Aug 20227:00 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirectorship Change
5th Aug 202211:45 amRNSDirector/PDMR Shareholding
27th Jul 202211:00 amRNSQ1 Trading Update and AGM Statement
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
8th Jul 202210:34 amRNSDirector/PDMR Shareholding
7th Jul 20227:00 amRNSDirector/PDMR Shareholding
23rd Jun 202210:25 amRNSNotice of AGM and Annual Report & Accounts
21st Jun 20227:00 amRNSFinal Results
12th May 202212:01 pmRNSHolding(s) in Company
24th Mar 20227:00 amRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading Update
26th Jan 20222:30 pmRNSDirector/PDMR Shareholding
21st Jan 202212:15 pmRNSDirector/PDMR Shareholding
20th Jan 202210:30 amRNSDirectorate Change
12th Jan 20222:00 pmRNSCorrection to Director/PDMR Shareholding
12th Jan 20227:00 amRNSDirector/PDMR Shareholding
26th Nov 20217:00 amRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSDirector/PDMR Shareholding
10th Nov 20215:57 pmRNSRecord Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.